Sernova (TSE:SVA) Shares Down 7.1% – Here’s What Happened

Shares of Sernova Corp. (TSE:SVA) fell 7.1% on Friday . The stock traded as low as C$0.13 and last traded at C$0.13. Approximately 209,050 shares changed hands during trading, an increase of 75% from the average session volume of 119,224 shares. The stock had previously closed at C$0.14.

Sernova Trading Down 7.1%

The business’s 50-day simple moving average is C$0.16 and its two-hundred day simple moving average is C$0.15. The firm has a market capitalization of C$49.09 million, a price-to-earnings ratio of -3.25 and a beta of -0.34. The company has a quick ratio of 18.11, a current ratio of 0.14 and a debt-to-equity ratio of -25.45.

Sernova (TSE:SVA) last issued its quarterly earnings data on Thursday, June 11th. The company reported C$0.01 EPS for the quarter. Equities analysts forecast that Sernova Corp. will post -0.08 earnings per share for the current year.

Sernova Company Profile

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.